SynAct Pharma AB

At a glance

Most recent filing on April 27, 2022 — an option exercise by Boesen Biotech ApS on Apr 22, 2022.

We hold 4 visible filings, going back to April 22, 2022.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

All 4 shown

This page is free to read, and it stops after 4 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Boesen Biotech ApS Closely associated: Other member of the administrative, management or supervisory body
26,191 sharesOption exercise
TradedApr 22, 2022FiledApr 27, 2022
BioInvest Aps Chief executive officer, Board member
3,656,899 sharesOption exercise
TradedApr 22, 2022FiledApr 27, 2022
Terje Kalland Board member
34,925 sharesOption exercise
TradedApr 22, 2022FiledApr 23, 2022
Patrik Renblad Chief financial officer
4,400 sharesOption exercise
TradedApr 22, 2022FiledApr 22, 2022